Skip to main content

Peer Review reports

From: An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

Original Submission
22 Dec 2023 Submitted Original manuscript
4 Jan 2024 Reviewed Reviewer Report
11 Jan 2024 Reviewed Reviewer Report - William David Wells-Gatnik
23 Jan 2024 Reviewed Reviewer Report - Lisa Bloudek
20 Feb 2024 Author responded Author comments - Xin Ying Lee
22 Feb 2024 Reviewed Reviewer Report - William David Wells-Gatnik
26 Feb 2024 Reviewed Reviewer Report
26 Feb 2024 Reviewed Reviewer Report - Lisa Bloudek
11 Mar 2024 Author responded Author comments - Xin Ying Lee
Resubmission - Version 2
20 Feb 2024 Submitted Manuscript version 2
Publishing
12 Mar 2024 Editorially accepted
18 Apr 2024 Article published 10.1186/s10194-024-01749-8

You can find further information about peer review here.

Back to article page